BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29242280)

  • 1. Results of Fertility-Sparing Surgery for Expansile and Infiltrative Mucinous Ovarian Cancers.
    Gouy S; Saidani M; Maulard A; Bach-Hamba S; Bentivegna E; Leary A; Pautier P; Devouassoux-Shisheboran M; Genestie C; Morice P
    Oncologist; 2018 Mar; 23(3):324-327. PubMed ID: 29242280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of patients with early stage mucinous ovarian carcinoma: a Dutch population-based cohort study comparing expansile and infiltrative subtypes.
    Algera MD; Van de Vijver KK; van Driel WJ; Slangen BFM; Lof FC; van der Aa M; Kruitwagen RFPM; Lok CAR
    Int J Gynecol Cancer; 2024 May; 34(5):722-729. PubMed ID: 38460968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility-Sparing Surgery in Infiltrative Mucinous Carcinoma of the Ovary.
    Ben Ltaief S; Ghalleb M; Chabchoub A; Slimen M; Hadj Kacem L; Zenzeri Y; Chargui R; Dhieb T
    Case Rep Oncol; 2023; 16(1):1494-1499. PubMed ID: 38033415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive age.
    Jiang X; Yang J; Yu M; Xie W; Cao D; Wu M; Pan L; Huang H; You Y; Shen K
    World J Surg Oncol; 2017 Aug; 15(1):154. PubMed ID: 28806962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility-sparing surgery in children and adolescents with borderline ovarian tumors: a retrospective study.
    Zhao J; Wang D; Wang R; He Y; Jia C; Pan L; Ma S; Wu M; Wang W; Cheng X; Yang J; Xiang Y
    J Ovarian Res; 2024 May; 17(1):96. PubMed ID: 38720349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of fertility-sparing surgery in young women with stage I endometrioid epithelial and mucinous ovarian cancer: A population-based analysis.
    Li J; Qiao H; Liu Y; Huang C; Cheng A; Lin Z; Wang L; Lu H
    Eur J Surg Oncol; 2024 Jan; 50(1):107276. PubMed ID: 38064863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of fertility-sparing surgery and further prognostic factors in borderline tumors of the ovary.
    Westermann T; Karabeg E; Heitz F; Traut A; Plett H; Moubarak M; Welz J; Heikaus S; Lax S; du Bois A; Harter P
    Int J Gynecol Cancer; 2024 Jun; 34(6):898-905. PubMed ID: 38627034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salpingo-oophorectomy versus cystectomy in patients with borderline ovarian tumors: a systemic review and meta-analysis on postoperative recurrence and fertility.
    Wang P; Fang L
    World J Surg Oncol; 2021 Apr; 19(1):132. PubMed ID: 33882931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes after fertility-sparing surgery of early-stage ovarian cancer: A nationwide population-based study.
    Lee CY; Chiang CJ; Tai YJ; Hsu HC; Chen YL; Chiang YC; Wu CY; Lee WC; Hwa HL; Cheng WF
    Cancer Med; 2024 Apr; 13(7):e7132. PubMed ID: 38606892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility potential and safety assessment of residual ovarian cortex in young women diagnosed with epithelial borderline and early-stage malignant ovarian tumors.
    Cacciottola L; Camboni A; Gatti E; Marbaix E; Vignali M; Donnez J; Dolmans MM
    Gynecol Oncol; 2024 Apr; 183():15-24. PubMed ID: 38492474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of histologic subtypes on survival outcomes in primary mucinous ovarian carcinoma.
    Lim H; Ju Y; Kim SI; Park JH; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Lee C; Lee M
    Gynecol Oncol; 2023 Oct; 177():117-124. PubMed ID: 37660413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility-Sparing Surgery and Adjuvant Chemotherapy with Trastuzumab Result in Complete Remission in a Young Woman with Rare Primary Mucinous Ovarian Cancer due to ERBB2 Co-amplification with CDK12 and Chromosome 11q13.3 Amplicon: A Case Report and Literature Review.
    Gao L; Huang T; Zhong L; Peng L; Huang Z; Lu Y
    Reprod Sci; 2024 Jun; 31(6):1626-1631. PubMed ID: 38216775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinicopathological characteristics and survival outcomes of primary expansile
    Nistor S; El-Tawab S; Wong F; Zouridis A; Roux R; Manek S; Gaitskell K; Ahmed AA; Kehoe S; Soleymani Majd H
    Transl Cancer Res; 2023 Oct; 12(10):2682-2692. PubMed ID: 37969399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-cause and cancer-specific mortality after fertility-sparing surgery for stage IA and IC epithelial ovarian cancer.
    Jorgensen K; Denham C; Kanbergs A; Wu CF; Nitecki R; Agusti N; Meernik C; Melamed A; Rauh-Hain JA
    Gynecol Oncol; 2023 Nov; 178():60-68. PubMed ID: 37801736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current limits of conservative treatment in ovarian cancer.
    Gracia M; Alonso-Espías M; Zapardiel I
    Curr Opin Oncol; 2023 Sep; 35(5):389-393. PubMed ID: 37498109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary mucinous ovarian cancer: options for surgery and chemotherapy.
    Kurnit KC; Frumovitz M
    Int J Gynecol Cancer; 2022 Oct; ():. PubMed ID: 36229081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic and reproductive outcomes after fertility-sparing surgery for bilateral borderline ovarian tumors: A retrospective study.
    Guo L; Kang X; Su Y; Liu X; Xie W; Meng S; Liu Y; Wang W; Wang C
    Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():107-113. PubMed ID: 38422803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191 conservative treatments.
    Uzan C; Nikpayam M; Ribassin-Majed L; Gouy S; Bendifallah S; Cortez A; Rey A; Duvillard P; Darai E; Morice P
    Ann Oncol; 2014 Jul; 25(7):1312-1319. PubMed ID: 24713312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian-sparing surgery for ovarian tumors in children: A systematic review and meta-analysis.
    Pio L; Abu-Zaid A; Zaghloul T; Halepota HF; Davidoff AM; Losty PD; Abdelhafeez HH
    Eur J Surg Oncol; 2023 Oct; 49(10):106923. PubMed ID: 37211469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating age and ethnicity as novel high-risk phenotypes in mucinous ovarian cancer: retrospective study in a multi-ethnic population.
    Olaoye T; - A; Boyle W; Williams A; Ganesan R; Subba K; Goyal A; Leung E; Chowdhary R; Pascoe J; Williams S; Yap J; Balega J; Kumar S; Singh K; Sundar SS
    Int J Gynecol Cancer; 2024 Jun; ():. PubMed ID: 38862154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.